Hims & Hers Health Faces Securities Class Action Lawsuit
Hims & Hers Health and certain executives are now facing a securities class action lawsuit. The action stems from a federal complaint filed by the FTC, which accuses the company of serious business practices.
Hims & Hers Health, Inc. (NYSE: HIMS) and some of its executives are now the subject of a securities class action lawsuit. This legal action follows a sweeping federal complaint filed by the U.S. Federal Trade Commission (FTC), which accuses the company of serious business practices.
While the specific nature of the FTC's allegations is not detailed in the provided information, such complaints typically involve accusations related to marketing, sales tactics, or product claims. The FTC's involvement suggests potential regulatory scrutiny.
Investors who have incurred losses in Hims & Hers Health stock are encouraged to contact the law firm Hagens Berman. The deadline to serve as lead plaintiff in the class action is November 2, 2026.
Securities class actions are legal proceedings initiated by investors who allege that a company made false or misleading statements, impacting the stock's value. These cases can be complex and time-consuming, seeking damages for affected shareholders.